PUK25 USING GENETIC POLYMORPHISM AS A STRATEGY TO ESTIMATE THE POTENTIAL COST-EFFECTIVENESS OF PHARMACOLOGICAL CCR5 BLOCKADE IN DIALYSIS PATIENTS
Abstract
Authors
S Vegter FL Muntinghe M Verduijn EW Boeschoten FW Dekker G Navis MJ Postma